Event Detail
ExL Pharma's European Lean Sigma and Kaizen for Life Sciences R&D
September 10 - 11, 2009
- Paris FRANCE
ExL Pharma
At the 2nd Lean Sigma & Kaizen for Pharma R&D event, over 30 different pharmaceutical companies in attendance discussed being confronted with increasing development time and costs for new drug development, and a decreasing probability of technical success. They all agreed that the rate of new drug approvals is not keeping pace with the rising cost of R&D spending, and investment into innovation is becoming very risky. Incorporating process improvement methodology – Lean & Six Sigma – was a solution that has proven to provide significant financial benefits and reductions to development cycle times. Increased drug candidate quality, meeting patient recruitment goals and decreasing outsourcing budgets are just a few of the results that continuous improvement has driven. R&D and innovation do provide a different set of challenges then the traditional application to manufacturing, but process improvement efforts are still a fit for R&D. I urge you to join us this September and continue the discussion. Hear presentations from senior-level executives sharing applications of process improvement tools across the life sciences R&D and clinical spectrums. Find out why Six Sigma belts are required for some pharma executives and reap the financial benefits that process improvement is providing. I look forward to seeing you in Paris.